510(k) K953761
K953761 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "AXSYM TRICYCLIC ANTIDEPRESSANTS". The FDA issued a decision of Substantially Equivalent on November 22, 1995. The device falls under product code LFH (U.V. Spectrometry, Tricyclic Antidepressant Drugs), a Class II device regulated under 21 CFR 862.3910. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 22, 1995
- Date Received
- August 11, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- U.V. Spectrometry, Tricyclic Antidepressant Drugs
- Device Class
- Class II
- Regulation Number
- 862.3910
- Review Panel
- TX
- Submission Type